活体脏捐赠者的高血压对补体激活和纤维化没有影响
Kidney & blood pressure research
|May 9, 2025
概括
来自高血压捐赠者的脏捐赠对移植后的一年内移植补充体沉积和纤维化的影响最小. 这表明高血压可能不是活体脏捐献的显著排除标准.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植免疫学 移植免疫学
- 病理学 病理学 病理学
背景情况:
- 从历史上看,高血压是活体脏捐献的禁忌,因为人们担心脏衰竭的加速.
- 已知高血压会诱导补体沉积和纤维化,这可能会影响移植体的健康.
研究的目的:
- 评估捐赠者的高血压对补充体沉积和移植中的纤维化的影响.
- 为了比较高血压与正常血压活体脏捐赠者的移植组织学.
主要方法:
- 对238名活体捐赠者 (52名高血压患者) 的零时间和一年协议脏活检进行分析,以检测补充体沉积物 (C1q,C3c,MASP-2).
- 使用Sirius Red染色和基因表达分析对纤维化相关标记物的纤维化的评估.
- 与已故捐赠者的活检和高血压脏病患者的活检进行比较.
主要成果:
- 在所有活体供体活检中观察到最小的补体沉积物,无论高血压状态如何,与高血压脏病相比.
- 一年后的协议活检显示补充体沉积物没有显著变化,高血压捐赠者的纤维化仅略有,不显著增加.
- 基因表达分析表明,活体供体活检 (高血压和正常血压) 与已故供体活检分别聚集.
结论:
- 来自高血压捐赠者的活体脏捐赠对移植后一年的补体沉积和纤维化有很小或没有明显的影响.
- 这些发现挑战了对高血压患者作为活体脏捐赠者的传统排斥.
相关概念视频
01:18Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
01:20Renal Corpuscle
1.8K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
1.8K
01:45Kidney Structure
69.3K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
69.3K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
541
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
541
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
01:22Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352